Sea Change In Drug Assistance Programs May Be On Horizon
High-cost biologics continue to command a growing share of the overall pharmaceutical market, placing an increasing financial strain on both patients and payors.[1]...To view the full article, register now.
Already a subscriber? Click here to view full article